Business · 15/12/2005Updated: 10/17/2026 · 1 min read
FDA Submits Collection of Information for Review Under Paperwork Reduction Act
Summary
The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance, focusing on consumer-friendly formats for brief summaries in direct-to-consumer print advertisements for prescription drugs.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →